Ad A.A.M Masclee
Maastricht University Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ad A.A.M Masclee as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:58 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03652571 · Nortriptyline for the Treatment of Functional DyspepsiaMaastricht University Medical Center · terminated · Functional Dyspepsia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:58 UTC. The ranking covers the 200 most relevant of 125 PubMed records, and a shared surname and initials can bring in a namesake. All 125 on PubMed
- Risk factors of frequent exacerbations in difficult-to-treat asthma.Eur Respir J · 2005365 citationsRCR 10.5
- 288 citationsRCR 13.9
- Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men.Clin Sci (Lond) · 2016185 citationsRCR 7.0
- Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome.Clin Gastroenterol Hepatol · 200893 citationsRCR 3.0
- Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.Gastroenterology · 202091 citationsRCR 6.4
- 89 citationsRCR 3.0
- Effect of fat saturation on satiety, hormone release, and food intake.Am J Clin Nutr · 200988 citationsRCR 3.1
- 88 citationsRCR 3.9
- Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma.J Am Acad Dermatol · 200080 citationsRCR 2.6
- Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.Neurogastroenterol Motil · 201875 citationsRCR 4.3